Evidence map›Paper›PMID 19536298›Full record

ArticlePloS one2009

Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France.

Jonas Bonnedahl, Mirva Drobni, Michel Gauthier-Clerc, Jorge Hernandez, Susanne Granholm, Yves Kayser, Asa Melhus, Gunnar Kahlmeter, Jonas Waldenström, Anders Johansson and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 241 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Prevalence and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Antimicrobial Resistance and Pathotypes ofAnimals : an open access journal from MDPI · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genomic Insights into GlobalMicrobiology spectrum · 2023
    Article
  16. Article
  17. Occurrence of ESBL- and AmpC-ProducingAntibiotics (Basel, Switzerland) · 2023
    Article
  18. Antimicrobial Susceptibility of CommensalAnimals : an open access journal from MDPI · 2023
    Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jonas BonnedahlDepartment of Medical Sciences, Section of Infectious Diseases, Uppsala University, Uppsala, Sweden.
Mirva Drobni
Michel Gauthier-Clerc
Jorge Hernandez
Susanne Granholm
Yves Kayser
Asa Melhus
Gunnar Kahlmeter
Jonas Waldenström
Anders Johansson
Björn Olsen
Uppsala University · SELandstinget i Kalmar län · SETour du Valat · FRUmeå University · SEVäxjö Kommun · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extended Spectrum beta-Lactamase (ESBL) producing Enterobacteriaceae started to appear in the 1980s, and have since emerged as some of the most significant hospital-acquired infections with Escherichia coli and Klebsiella being main players. More than 100 different ESBL types have been described, the most widespread being the CTX-M beta-lactamase enzymes (bla(CTX-M) genes). This study focuses on the zoonotic dissemination of ESBL bacteria, mainly CTX-M type, in the southern coastal region of France. We found that the level of general antibiotic resistance in single randomly selected E. coli isolates from wild Yellow-legged Gulls in France was high. Nearly half the isolates (47.1%) carried resistance to one or more antibiotics (in a panel of six antibiotics), and resistance to tetracycline, ampicillin and streptomycin was most widespread. In an ESBL selective screen, 9.4% of the gulls carried ESBL producing bacteria and notably, 6% of the gulls carried bacteria harboring CTX-M-1 group of ESBL enzymes, a recently introduced and yet the most common clinical CTX-M group in France. Multi locus sequence type and phylogenetic group designations were established for the ESBL isolates, revealing that birds and humans share E. coli populations. Several ESBL producing E. coli isolated from birds were identical to or clustered with isolates with human origin. Hence, wild birds pick up E. coli of human origin, and with human resistance traits, and may accordingly also act as an environmental reservoir and melting pot of bacterial resistance with a potential to re-infect human populations.

Indexed as

AllelesAnimalsbeta-LactamasesCharadriiformesDrug Resistance, BacterialEscherichia coliEscherichia coli ProteinsFranceGeographyHumansMicrobial Sensitivity TestsModels, GeneticPhylogenyPolymerase Chain ReactionSpecies Specificitybeta-LactamasesEscherichia coli Proteins

Identifiers

PMID19536298
PMCPMC2694269
OpenAlexW1981076667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.